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Abstract 
Ethnopharmacological relevance: Rhodiola algida var. tangutica is a traditional Tibetan herb. Its root and rhizome 
have been successfully used as an effective clinical remedy for the prevention and treatment of cancer and high‑
altitude sickness. This study aimed to investigate the effect of Rhodiola algida var. tangutica on hypoxic MCF‑7 breast 
cancer cells and the underlying mechanisms.
Materials and methods: The antiproliferative effects of R. algida on MCF‑7 breast cancer cells were compared 
in vitro under hypoxic and normal conditions by using MTT analysis. The influence of R. algida on cancer cell apop‑
tosis was determined by flow cytometry. The expression levels of hypoxia‑inducible factor (HIF)‑1α and HIF‑2α were 
evaluated by western blot analysis.
Results: R. algida inhibited the proliferation of MCF‑7 breast cancer cells in a dose‑ and time‑dependent manner. The 
results of flow cytometry indicated that the antiproliferative effect of R. algida was mediated by apoptosis induction. 
Pretreatment with R. algida significantly suppressed the hypoxia‑induced proliferation and expression of HIF‑1α and 
HIF‑2α in MCF‑7 breast cancer cells.
Conclusions: R. algida might exert an anti‑carcinogenic effect on MCF‑7 breast cancer cells by decreasing the pro‑
tein levels of HIF‑1α and HIF‑2α, which are overexpressed under hypoxic conditions. This effect might be elicited by 
inhibiting the hypoxia‑induced proliferation of MCF‑7 breast cancer cells.
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Background
Breast cancer is the most common malignancy in women 
in China [1]. Its annual age-standardized incidence esti-
mates was 21.6 per 100,000 women in 2008. The mortal-
ity and incidence rates are substantially higher in urban 
compared to rural areas (35.6 versus 15.5 per 100,000; 
6.90 versus 4.60 per 100,000 in 2008) [2]. Breast cancer 
also seems more aggressive in China than in developed 
countries, although tumor size and stage at diagnosis 
decreases year by year [3]. Among women in economi-
cally developed Chinese provinces and cities, breast can-
cer has the highest incidence of all cancers.
Hypoxia is a common feature of solid tumour, most of 
the cancer cells grow fast and suffer nutrition and oxygen 
deficiency under hypoxia [4]. Hypoxia response path-
ways are complicated and offer many options for anti-
cancer treatment. One of the main and relatively hypoxic 
response pathways involves hypoxia-inducible factor 
(HIF)-1, which has therefore been studied as a tumor-
specific target for anticancer treatment [5, 6]. The HIF 
DNA binding complex is a heterodimer of alpha and beta 
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subunits, both of which are basic helix-loop-helix tran-
scription factors. The β-subunit of HIF is a constitutive 
nuclear protein, which is critically involved in a range of 
transcriptional systems, and was first identified in the con-
text of the xenobiotic response. In cells replete with oxy-
gen, HIF-α subunits are unstable, being rapidly destroyed 
by the ubiquitin–proteasome pathway. When oxygen ten-
sion is lowered, HIF-α subunits are stabilised, translocate 
to the nucleus, and dimerise with a beta subunit. HIF 
activation is indeed very common in malignant tumours, 
and have given insights into the underlying mechanisms. 
And activates transcription of a range of genes via specific 
enhancer elements termed hypoxia response elements.
Recently, research has been focused on a homologous 
member of the HIF family. Both factors, HIF-1 and HIF-
2, are regulated in similar ways but have different trans-
activation domains, implying that they may regulate 
distinct target genes [7, 8].
The key regulators of hypoxia-induced angiogenesis are 
the HIF family of protein transcription factors [9]. HIF 
regulates multiple factors such as VEGF, and nitric oxide 
synthases to promote tumor growth and angiogenesis. 
Hypoxic cells undergo a switch from aerobic to anaerobic 
glucose metabolism. This adaptive response to hypoxia 
involves the coordinated expression of many genes regu-
lated by HIF, such as those that encode GLUT1, GLUT3, 
and various glycolytic enzymes [10].
The genus Rhodiola L. (Crassulaceae) consists of nearly 
200 species in which 20 species are commonly used in 
traditional medical practice in Eastern Europe and Asia 
[10, 11]. Of these 20 species, Rhodiola algida, Rhodiola 
rosea, Rhodiola sachalinensis, Rhodiola kirilowii, Rho-
diola crenulata, Rhodiola stropupurea, Rhodiola qundri-
fida, and Rhodiola sera are the most effective ones.
In China, R. crenulata H. Ohba is the only authorized 
herb according to Chinese Pharmacopoeia. However, 
many other species are also popular in folk medicines 
such as R. algida. Rhodiola algida var. tangutica is a tra-
ditional Tibetan herb and grows at an altitude of 3,000–
4,500  m in the Qinghai-Tibetan plateau. The medicinal 
use of the plant is usually concentrated in the roots and 
rhizomes that contain its main bioactive compounds [12].
Rhodiola plants are prescribed to increase physical 
endurance, work productivity, longevity, resistance to 
high latitude sickness, and to treat fatigue, depression, 
nervous system disorders, etc. [13]. R. algida is one of 
the most effective species of Rhodiola L. and has been 
clinically proven to enhance human immune responses 
[10, 11]. Despite these findings, the role of R. algida as an 
immunomodulatory agent has been established [14].
Salidroside is regarded as the most important bioactive 
component and has been used extensively as an indicator for 
quality evaluation of many Rhodiola species and products 
[15]. Salidroside and tyrosol were the main component of 
Rhodiola algida var. tangutica [16]. Therefore, salidroside 
was selected in this study as a standard marker to evaluate 
the quality consistency among different batches of R. algida.
The effective components of Rhodiola have been stud-
ied extensively during recent years; the extract of Rhodiola 
algida var. tangutica inhibits division of MCF-7 cells and 
the cytostatic and antiproliferative effect was related to 
apoptosis induction mechanism [16]. However, whether 
it plays an anti-carcinogenic effect under hypoxia condi-
tion is yet unclear. The aim of the study is Rhodiola algida 
var. tangutica inhibits tumor cell proliferation and tran-
scription factor regulation under hypoxia. In this study, 
we investigated the pharmacological effect of Rhodiola 
on the proliferation of hypoxic MCF-7 cells. In addition, 
HIF-1α and HIF-2α expression levels in cultured MCF-7 
cells exposed to hypoxia were estimated in vitro.
Methods
Reagents
MCF-7 breast cancer cells were purchased from Shang-
hai Institute for Biological Sciences. The effective com-
ponents of R. algida var. tangutica were isolated and 
analyzed by high-performance liquid chromatography 
(HPLC) at the Northwest Institute of Plateau Biology, 
Chinese Academy of Sciences. The antibodies against 
HIF-1α, HIF-2α, and glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) were purchased from Abcam (UK). 
Annexin V-FITC was purchased from BD Biosciences 
(San Jose, CA, USA). Fetal bovine serum (FBS) and anti-
biotics were purchased from Gibco/RBL (Gaithersburg, 
MD, USA).All other reagents were made in China.
Extract preparation
The rhizomes of ground plants of Rhodiola algida var. 
tangutica were grown for 3  years in the experimental 
field of Yushu (altitude 3,800 m) in Qinghai.
The plant material was dried at 80°C. Next, 10 g of the 
ground dry raw material was mixed with 60  mL of 96% 
ethanol. Extraction was carried out in flasks placed on a 
rotary shaker at 25°C in dark for 12 h. The extract was fil-
tered, and the filtrate was evaporated at 35°C, at reduced 
pressure (20 mbar). The dry residue (0.23 g) was dissolved 
in 5 mL dimethyl sulfoxide (DMSO) to a final concentra-
tion of 2–4.6%. This solution was diluted with distilled 
water to obtain the following dilutions: 45, 90, 180, 225, 
360, and 450 μg/mL; the maximal concentration of DMSO 
in the obtained dilutions did not exceed 0.5%. A solution of 
0.5% DMSO was used as a control in all our experiments.
HPLC analysis
HPLC analysis was performed using a Phenomenex Kro-
masil C18 column (5 m, 250 mm × 460 mm), equipped 
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with a UVD detector. Separation was performed using an 
EC 250/4 Nucleosil® 120-7C18 column (Machery-Nogel). 
The mobile phase consisted of methanol (A) and 0.01 M 
H3PO4 (B), used in the following gradient elution: from 5% 
A for 0 min to 5% A for 10 min to 100% A for 60 min. The 
flow rate was 1  mL/min, and the detection wavelength 
was 220 nm. The results of our investigations determined 
that the main component of Rhodiola algida Var. tangu-
tica contained salidroside and tyrosol [16]. The standard 
substances, i.e., salidroside [15], tyrosol, and other frac-
tions were analyzed in the same manner. The standard 
substances purchased from China’s food and drug veri-
fication research institute (110818–201206). Peaks were 
assigned by spiking the samples with standard substances 
and comparing the retention times and UV spectra.
Cell culture
Cells were cultured in RPMI 1640 containing 10% (v/v) 
fetal bovine serum (FBS, Gibco) with 100 U/mL penicillin 
and 100 U/mL streptomycin at 37°C. The fourth to sixth 
generation cells were used for the subsequent experi-
ments. Cells were exposed to normoxia (74% N2, 5% CO2, 
and 21% O2) and hypoxia (93% N2, 5% CO2, and 2% O2).
Morphological changes
The cells were visually and microscopically inspected each 
time they were handled. Signs of deterioration of cells 
included granularity around the nucleus, detachment of 
the cells from the substrate, and cytoplasmic vacuolation.
Viability studies
MCF-7 cells were incubated in a metabolic water bath 
for 72  h under normoxic condition. Control tubes con-
tained only cells and incubation medium with DMSO 
and experimental tubes contained cells in medium along 
with different concentrations of R. algida extract (45, 90, 
180, 225, 360, and 450 μg/mL). One tube from each of 
the 6 experimental sets was withdrawn at 0, 6, 12, 24, 48, 
and 72  h after incubation and immediately assessed for 
viability by the trypan blue exclusion method.
Proliferation assays
The proliferation of MCF-7 breast cancer cells was meas-
ured using 3-(4, 5-dimethylthiazal-2-yl)-2, 5-diphe-
nyltetra-zoliumbromide (MTT) assay by colorimetrically 
measuring the formation of formazan dye. Briefly, MCF-7 
breast cancer cells were seeded at a density of 10,000 cells/
cm2 in 96-well plates. The cells were incubated for 24  h 
in serum-free RPMI1640 and then exposed to R. algida 
extract (0, 45, 90, 180, 225, 360, and 450 μg/mL) for 48 h 
under normoxia or hypoxia condition, namely, N48  h or 
H48 h group, respectively. Plain RPMI1640 was used as the 
negative control. At the end of treatment, MTT (0.25 mg/
mL, Sigma, USA) was added to the plates, and incubation 
was continued for another 4  h at 37°C. The supernatant 
was then carefully removed, and 150  µL of DMSO was 
added to dissolve the formazan crystals. The absorbance 
of the solubilized product was read at 490 nm (A490) by 
using an ELISA reader (Bio-Rad, USA). All determinations 
were replicated at least three times.
The effects of hypoxia on MCF-7 cells were investi-
gated by measuring cell proliferation by direct cell count-
ing. Cells were seeded at a density of 10,000 cells/cm2 in 
12-well plates and incubated in serum-free RPMI1640 for 
24 h. They were then stimulated with R. algida extract at 
0, 45, 90, 180, 225, 360, and 450 μg/mL. After 48 h, they 
were washed with phosphate buffered solution, harvested 
by mild trypsinization, and counted using a hematocy-
tometer. The experiments were conducted under both 
hypoxic and normoxia conditions.
Flow cytometry
The mode of cell death via apoptosis and or necrosis 
produced by the extract treatment in MCF-7 cells was 
determined by flow cytometry after staining the cells 
with Annexin V-FITC and PI. Cells were stimulated with 
R. algida extract at 0, 45, 90, 180, 225, 360, and 450 μg/
mL for 48  h under normoxia or hypoxia. Treated cells 
were washed twice with cold PBS and then resuspended 
in binding buffer at a concentration of 1 × 105 cells/mL. 
Next, 5 µL of Annexin V-FITC and 10 µL of propidium 
iodide were added to suspended cells. After incubation 
for 10 min at room temperature in the dark, the percent-
age of apoptotic cells was calculated using a flow cytom-
eter (Becton–Dickinson, USA) equipped with argon laser 
having an emission spectrum of 488 nm. The percentages 
of apoptotic and necrotic cells were evaluated.
Determination of HIF‑1α and HIF‑2α expression by western 
blot analysis
MCF-7 cells were exposed to normoxia or hypoxia in the 
absence or presence of R. algida extract in the indicated 
concentrations. Cells were lysed in whole lysis buffer (0.1% 
Nonidet P-40, 5  mM ethylenediaminetetraacetic acid 
(EDTA), 50 mM Tris (pH 8.0), 250 mM NaCl, and 50 mM 
NaF), and protein concentrations were determined using 
the Bio-Rad Protein assay (Bradford). Subsequently, 30 μg 
protein was resolved on 10% sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis (SDS-PAGE) and transferred 
to nitrocellulose membranes. The membranes were blocked 
with 5% skimmed milk–PBS/0.1% Tween20 for 2  h before 
an overnight incubation at room temperature with primary 
antibodies in 5% skimmed milk in PBS/0.1% Tween20. 
The corresponding secondary antibody was washed with 
Tris-buffered saline with Tween20 (TBST) for 30  min and 
added to the membranes, followed by incubation at room 
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temperature for 2 h. The membranes were then washed three 
times for 10 min each with TBST. Detection was performed 
using the enhanced chemiluminescence system (Amersham, 
Arlington Heights, IL, USA). The relative expression lev-
els of HIF-1α and HIF-2α were normalized against that of 
GAPDH.
Statistical analysis
The statistical significance of differences between groups 
was evaluated by one-way analysis of variance (ANOVA), 
followed by Dunnett’s test for multiple comparisons. A p 
value of < 0.05 was considered as statistically significant.
Results
Effect of hypoxia on MCF‑7 cell proliferation
MCF-7 breast cancer cells were cultured under hypoxic or 
normoxic condition for 12, 24, 48, and 72 h, as described 
previously. Subsequently, cell proliferation was measured 
by the MTT assay. The absorbance at 490 nm was detected. 
Hypoxia-induced MCF-7 breast cancer cells showed pro-
liferation especially at 48  h (Table  1). Therefore, 48  h of 
incubation was used for the subsequent experiments.
In vitro viability studies on cytotoxicity of R. algida var. 
tangutica
The cytotoxicity of R. algida extract on MCF-7 
cells was evaluated by the trypan blue dye exclusion 
method, and the appropriate concentrations of the 
plant extract to be used was determined. The MCF-7 
(2  ×  105 cells/well) breast cancer cells were incu-
bated for 24  h in 96-well plates with various concen-
trations of R. algida extract (0, 45, 90, 180, 225, 360, 
and 450  μg/mL). Dose-dependent cytotoxic effect of 
the plant extract against MCF-7 breast cancer cells is 
shown in Fig. 1. The concentration of 450 μg/mL sig-
nificantly decreased the number of viable cells and 
produced microscopic changes in morphology com-
pared with those of the controls. Hence, the doses of 
360 μg/mL or less were selected for subsequent exper-
iments since these doses had weak cytotoxic effects 
on MCF-7 cells. However, with increasing incubation 
times, even low doses of R. algida extract significantly 
decreased cell viability.
Morphology
Morphological changes in MCF-7 breast cancer cells 
treated with R. algida extract under 2.0% O2 or normoxic 
condition were observed microscopically (Fig.  2). The 
cells showed shrinkage, chromatin compaction, and cyto-
plasmic vacuolation. Treatment with R. algida extract 
increased the apoptotic cell numbers (Fig.  2). Cell mor-
phology was markedly changed after 48  h incubation 
with 360 μg/mL R. algida extract.
Table 1 Effect of hypoxic on proliferation of MCF-7 breast 
cancer cells (absorbance at 490 nm, A490)
The data represented mean ± S.D. (n = 15).
a P < 0.05 vs. normoxia.
12 h 24 h 48 h 72 h
Normoxia 0.272 ± 0.023 0.289 ± 0.019 0.315 ± 0.031 0.331 ± 0.003
Hypoxia 0.298 ± 0.031 0.319 ± 0.044a 0.351 ± 0.034a 0.362 ± 0.044a
Fig. 1 Effect of Rhodiola algida var. tangutica on the viability of MCF‑7 cell. MCF‑7 cell were cultured in microwells and incubated with increasing 
concentrations of Rhodiola algida var. tangutica 0, 6, 12, 24, 48 and 72 h after incubation with different concentrations of Rhodiola algida var. tan-
gutica, percentage viability of MCF‑7 cell was determined by trypan blue exclusion. The highest concentration (450 μg/mL) of Rhodiola algida var. 
tangutica caused a significant decrease in cell viability compared with control.
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Identification of apoptosis by flow cytometry analysis
The percentage of MCF-7 cells increased under the 
hypoxic condition, but this increase in cell proliferation 
was markedly decreased by treatment with R. algida 
extract (Fig.  3). The data represented mean  ±  S.D. 
(n =  15). P  <  0.05 vs. normoxia. This suggested that R. 
algida var. tangutica induced apoptosis under hypoxia in 
MCF-7 breast cancer cells.
Effects of R. algida extract on MCF‑7 breast cancer cell 
proliferation under normoxic and hypoxic conditions
Evaluation of whether R. algida extract affected the pro-
liferation of MCF-7 cells induced by hypoxia was per-
formed using the MTT assay and direct cell counting 
for nonradioactive quantification of cell proliferation. 
The results showed that R. algida extract inhibited the 
hypoxia-induced proliferation of MCF-7 cells in a con-
centration-dependent manner. Significantly reduced cell 
proliferation of treated cells was also noted under nor-
moxic condition, although at lower concentrations of 
R. algida extract (180 and 225 μg/mL; Table 2). Similar 
results were obtained by direct cell counting (Fig. 4).
Effect of R. algida extract on HIF‑1α and HIF‑2α protein 
expression in cultured MCF‑7 breast cancer cells
Hypoxia increased the expressionof HIF-1α and HIF-2α 
in MCF-7 breast cancer cells, whereas treatment with R. 
algida extract (225 and 360  μg/mL) possibly decreased 
Fig. 2 Rhodiola algida var. tangutica inhibits hypoxia‑induced proliferation in MCF‑7 cells. The cells were plated at a seeding density of 5 × 104 
viable cells/cm2 and grown as a monolayer in a 37°C incubator with a humidified atmosphere of 5% CO2 in a 2.0% O2 or normoxic. The images were 
obtained using 20× objectives 48 h after plating. a Morphology from normal MCF‑7 breast cancer cells in adherent culture exposed to normoxic 
48 h (N48h). b Morphology from MCF‑7 breast cancer cells in adherent culture exposed to hypoxia 48 h (H48h), showing proliferation after expo‑
sure to hypoxia. c Morphology from MCF‑7 breast cancer cells in adherent culture receiving Rhodiola algida var. tangutica (360 μg/mL) for 48 h 
under normoxic condition (N48h + Rhodiola algida var. tangutica group), showing shrinkage and chromatin compaction in normal MCF‑7 breast 
cancer cells. d Morphology from MCF‑7 breast cancer cells in adherent culture receiving Rhodiola algida var. tangutica (360 μg/mL) after exposure 
to hypoxia for 48 h (H48h + Rhodiola algida var. tangutica group).
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HIF-1α and HIF-2α protein expression in cells exposed to 
hypoxia for 48 h (Fig. 5, a–c).
Discussion
Breast cancer has an incidence rate of 16.39 per 100,000 
Chinese women and seriously affects the lives and health 
of this population. Gene targeting involving substances 
that target hypoxic cells might be an excellent strategy. 
The transcriptional factor HIF-1 plays an essential role 
in the adaptive response of cells to reduced oxygen ten-
sion [17]. The induction of HIF-1α is a critical step in the 
induction of hypoxic response and occurs via increased 
mRNA expression, protein stabilization, and nuclear 
localization. Additional isoforms of the α-subunit termed 
HIF-2α and HIF-3α are present. HIF-2α is closely related 
to HIF-1α, and both subunits can interact with hypoxia-
response elements to upregulate their transcriptional 
activity [18]. In contrast, HIF-3α is involved in the down-
regulation of the hypoxic response via the activation of 
an alternatively spliced transcription factor, which may 
function as an inhibitor of HIF-1α [19]. An efficient gene 
delivery system needs to be developed to increase the effi-
ciency and reduce toxicity of Rhodiola spp. The property 
of Rhodiola spp. to suppress the proliferation of cancer 
cells under hypoxic condition can be used to induce ther-
apeutic gene expression specifically in the tumor tissue.
Extract of R. algida has been known to exert many 
beneficial effects in the treatment of numerous diseases, 
Fig. 3 Induction of apoptosis and/or necrosis assessed by flow cytometry. Externalization of phosphotidylserine (PS) to the outer leaflet from the 
inner leaflet of the plasma membrane is a hallmark of early apoptosis. The FITC labeled Annexin V binds to PS in presence of calcium ions, resulting 
in green fluorescence of apoptotic cells. In later stages of apoptosis or necrosis, PI enters the cells and bind to cellular DNA, resulting in red and 
intense green fluorescence with Annexin V. As shown in the Fig. 3, cells treated with the lower concentration showed the present of Annexin V (+) 
(lower right quadrant) indicating the induction of early apoptosis. However, at higher concentration, there was a prominent rise of Annexin V(+)/PI 
(+) indicative of late apoptosis/necrosis.
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probably via different mechanisms reported. For exam-
ple, salidroside protects endothelial cells from cobalt 
chloride-induced apoptosis by acting as an antioxidant 
and regulating the expression of Bcl-2 family members 
[20]. The protective effect of salidroside has been shown 
to be closely associated with the activation of the tran-
scription factor HIF-1α along with its target gene VEGF 
[21]. Previous studies have shown that treatment of 
human peripheral blood mononuclear cells (PBMCs) 
with Rhodiola aqueous extract (RAE) increased the levels 
of interleukin (IL)-6 and tumor necrosis factor-α (TNF-
α) via the phosphorylation of IκB and transcription factor 
NF-κB; this suggests that RAE has immunostimulatory 
potential [22]. In some previous study, we found that 
R. rosea aqueous extract, hydroalcoholic extract, and 
rosavin induced anti-angiogenic activity in the tumor-
induced angiogenesis model [23]. Oral administration 
of R. rosea extract to patients with superficial bladder 
carcinoma led to the improvement in the characteristics 
of the urothelial tissue integration and T cell immunity 
[24]. Salidroside induces cell-cycle arrest and apopto-
sis in human breast cancer cells and may be a promising 
candidate for breast cancer treatment [25].
The R. rosea extract and salidroside inhibit transla-
tion initiation. Both the R. rosea extract and salidroside 
treatment of UMUC3 bladder cells caused a significant 
percentage of cells undergoing autophagy. The R. rosea 
extract and salidroside deserve further study as novel 
agents for chemoprevention of bladder carcinogen-
esis [26]. The inhibitory effects of salidroside on tumor 
metastasis in human fibrosarcoma HT1080 cells in vitro. 
Salidroside inhibits tumor cells metastasis, which may 
due to its interfere in the intracellular excess ROS thereby 
down-regulated the ROS-PKC-ERK1/2 signaling pathway 
[27]. Angiogenesis was induced in the skin of Balb/c mice 
by grafting of syngeneic L-1 sarcoma cells. Mice were 
Table 2 Effect of  Rhodiola algida Var. tangutica on  proliferation of  MCF-7 breast cancer cells exposed to  normoxia 
and hypoxia for 48 h (absorbance at 490 nm, A490)
The data represented mean ± S.D. (n = 9). N48 h indicates exposure to normoxia for 48 h; H48 h, exposure to hypoxia for 48 h.
a P < 0.05 vs. N48 h in the absence of Rhodiola algida var. tangutica.
b P < 0.05 vs. H48 h in the absence of Rhodiola algida var. tangutica.
Rhodiola algida var. tangutica 0 μg/mL 45 μg/mL 90 μg/mL 180 μg/mL 225 μg/mL 360 μg/mL 450 μg/mL
N48 h 0.301 ± 0.070 0.296 ± 0.059 0.284 ± 0.067 0.273 ± 0.058 0.265 ± 0.043 0.247 ± 0.045a 0.239 ± 0.062a
H48 h 0.358 ± 0.048 0.346 ± 0.054 0.327 ± 0.078 0.314 ± 0.057 0.308 ± 0.071b 0.274 ± 0.067b 0.266 ± 0.074b
Fig. 4 Effect of Rhodiola algida var. tangutica on proliferation of MCF‑7 breast cancer cells exposed to normoxia and hypoxia for 48 h by direct cell 
counting. Serum‑starved MCF‑7 breast cancer cells exposed to normoxia and hypoxia were incubated with Rhodiola algida var. tangutica at different 
concentrations (0, 45, 90, 180, 225, 360 μg/mL) for 48 h. And then the cell counts were determined with a hematocytometer. Values are expressed 
as percentage of untreated cells, and each bar represents the mean ± S.D. of triplicate determinations. N48 h indicates exposure to normoxia for 
48 h; H48 h, exposure to hypoxia for 48 h. ※P < 0.05 vs. N48 h in the absence of Rhodiola algida var. tangutica. ▲P < 0.01 vs. N48 h in the absence of 
Rhodiola algida var. tangutica; ★P < 0.05 vs. H48 h in the absence of Rhodiola algida var. tangutica.
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fed R. quadrifida extract or salidroside in daily different 
doses. After 72  h, R. quadrifida extract and salidroside 
significantly decreased neovascular reaction in all doses 
applied [23].
In the present study, cultured MCF-7 breast cancer 
cells exposed to R. algida extract at concentrations of 
45–360 μg/mL for 48 h showed no signs of toxicity. The 
effects of hypoxia on the proliferation of MCF-7 breast 
cancer cells and expression of HIF subunits was also 
studied. Majewska reported that the rhizome extract 
of R. rosea inhibits cell division, induces apoptosis and 
necrosis, and elicits cytostatic and anti-proliferative 
effects in HL-60 cells [28]. Our results are in agreement 
with previously reported findings and suggest that R. 
algida var. tangutica prevents the hypoxia-induced pro-
liferation of MCF-7 cells and down-regulates the expres-
sion of HIF-1α and HIF-2α.
Conclusion
In our research,We found that the proliferation of MCF-7 
breast cancer cells increased significantly under hypoxia 
compared with that of the controls. Our results showed 
that pretreatment of MCF-7 breast cancer with R. algida 
extract increased cell apoptosis. Moreover, morphologi-
cal and FACS analyses clearly showed that MCF7 cell 
proliferation was significantly inhibited by pretreatment 
with R. algida extract under hypoxia. In addition, pro-
tein expression of HIF-1α and HIF-2α in MCF-7 cells 
was inhibited by pretreatment with R. algida extract. R. 
algida extract maybe as a potential anti-tumor medicane 
in the future. Although our experiments were performed 
in vitro, the results provide a basis for using R. algida var. 
tangutica in the treatment of hypoxic breast cancer.
We want to detect the effect of R. algida var. tangutica 
on tumor in vivo in our future research job.
Fig. 5 Effects of hypoxia and Rhodiola algida var. tangutica on HIF‑1α, HIF‑2α protein expression in MCF‑7 cells cultured detected by Western blot‑
ting. a Western blots of cultured MCF‑7 breast cancer cells exposed to hypoxia for 48 h in the absence or presence of various concentrations of Rho-
diola algida var. tangutica (45, 90, 180, 225, 360 μg/mL). Cell lysates were analyzed by Western blotting with antibodies as indicated above. GAPDH 
protein expression was used as a control. b, c Bars show the relative expression levels of HIF‑1α, HIF‑2α (optical density of HIF‑1α, HIF‑2α normalized 
against GAPDH expression). Data are mean ± SEM of three identical experiments. N48 h indicates exposure to normoxia for 48 h; H48 h, exposure to 
hypoxia for 48 h. ◆P < 0.01 vs. N48 h group, ★P < 0.05 vs. H48 h group.
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